table of content
1 Study Coverage
1.1 Live Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Live Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Monovalent Live Vaccines
1.2.3 Multivalent Live Vaccines
1.3 Market by Application
1.3.1 Global Live Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Adults
1.3.3 Children
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Live Vaccines Sales Estimates and Forecasts 2017-2028
2.2 Global Live Vaccines Revenue Estimates and Forecasts 2017-2028
2.3 Global Live Vaccines Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Live Vaccines Sales by Region
2.4.1 Global Live Vaccines Sales by Region (2017-2022)
2.4.2 Global Sales Live Vaccines by Region (2023-2028)
2.5 Global Live Vaccines Revenue by Region
2.5.1 Global Live Vaccines Revenue by Region (2017-2022)
2.5.2 Global Live Vaccines Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Live Vaccines Sales by Manufacturers
3.1.1 Global Top Live Vaccines Manufacturers by Sales (2017-2022)
3.1.2 Global Live Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Live Vaccines in 2021
3.2 Global Live Vaccines Revenue by Manufacturers
3.2.1 Global Live Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Global Live Vaccines Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Live Vaccines Revenue in 2021
3.3 Global Live Vaccines Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Live Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Live Vaccines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Live Vaccines Sales by Type
4.1.1 Global Live Vaccines Historical Sales by Type (2017-2022)
4.1.2 Global Live Vaccines Forecasted Sales by Type (2023-2028)
4.1.3 Global Live Vaccines Sales Market Share by Type (2017-2028)
4.2 Global Live Vaccines Revenue by Type
4.2.1 Global Live Vaccines Historical Revenue by Type (2017-2022)
4.2.2 Global Live Vaccines Forecasted Revenue by Type (2023-2028)
4.2.3 Global Live Vaccines Revenue Market Share by Type (2017-2028)
4.3 Global Live Vaccines Price by Type
4.3.1 Global Live Vaccines Price by Type (2017-2022)
4.3.2 Global Live Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Live Vaccines Sales by Application
5.1.1 Global Live Vaccines Historical Sales by Application (2017-2022)
5.1.2 Global Live Vaccines Forecasted Sales by Application (2023-2028)
5.1.3 Global Live Vaccines Sales Market Share by Application (2017-2028)
5.2 Global Live Vaccines Revenue by Application
5.2.1 Global Live Vaccines Historical Revenue by Application (2017-2022)
5.2.2 Global Live Vaccines Forecasted Revenue by Application (2023-2028)
5.2.3 Global Live Vaccines Revenue Market Share by Application (2017-2028)
5.3 Global Live Vaccines Price by Application
5.3.1 Global Live Vaccines Price by Application (2017-2022)
5.3.2 Global Live Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America Live Vaccines Market Size by Type
6.1.1 North America Live Vaccines Sales by Type (2017-2028)
6.1.2 North America Live Vaccines Revenue by Type (2017-2028)
6.2 North America Live Vaccines Market Size by Application
6.2.1 North America Live Vaccines Sales by Application (2017-2028)
6.2.2 North America Live Vaccines Revenue by Application (2017-2028)
6.3 North America Live Vaccines Market Size by Country
6.3.1 North America Live Vaccines Sales by Country (2017-2028)
6.3.2 North America Live Vaccines Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Live Vaccines Market Size by Type
7.1.1 Europe Live Vaccines Sales by Type (2017-2028)
7.1.2 Europe Live Vaccines Revenue by Type (2017-2028)
7.2 Europe Live Vaccines Market Size by Application
7.2.1 Europe Live Vaccines Sales by Application (2017-2028)
7.2.2 Europe Live Vaccines Revenue by Application (2017-2028)
7.3 Europe Live Vaccines Market Size by Country
7.3.1 Europe Live Vaccines Sales by Country (2017-2028)
7.3.2 Europe Live Vaccines Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Live Vaccines Market Size by Type
8.1.1 Asia Pacific Live Vaccines Sales by Type (2017-2028)
8.1.2 Asia Pacific Live Vaccines Revenue by Type (2017-2028)
8.2 Asia Pacific Live Vaccines Market Size by Application
8.2.1 Asia Pacific Live Vaccines Sales by Application (2017-2028)
8.2.2 Asia Pacific Live Vaccines Revenue by Application (2017-2028)
8.3 Asia Pacific Live Vaccines Market Size by Region
8.3.1 Asia Pacific Live Vaccines Sales by Region (2017-2028)
8.3.2 Asia Pacific Live Vaccines Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Live Vaccines Market Size by Type
9.1.1 Latin America Live Vaccines Sales by Type (2017-2028)
9.1.2 Latin America Live Vaccines Revenue by Type (2017-2028)
9.2 Latin America Live Vaccines Market Size by Application
9.2.1 Latin America Live Vaccines Sales by Application (2017-2028)
9.2.2 Latin America Live Vaccines Revenue by Application (2017-2028)
9.3 Latin America Live Vaccines Market Size by Country
9.3.1 Latin America Live Vaccines Sales by Country (2017-2028)
9.3.2 Latin America Live Vaccines Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Live Vaccines Market Size by Type
10.1.1 Middle East and Africa Live Vaccines Sales by Type (2017-2028)
10.1.2 Middle East and Africa Live Vaccines Revenue by Type (2017-2028)
10.2 Middle East and Africa Live Vaccines Market Size by Application
10.2.1 Middle East and Africa Live Vaccines Sales by Application (2017-2028)
10.2.2 Middle East and Africa Live Vaccines Revenue by Application (2017-2028)
10.3 Middle East and Africa Live Vaccines Market Size by Country
10.3.1 Middle East and Africa Live Vaccines Sales by Country (2017-2028)
10.3.2 Middle East and Africa Live Vaccines Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Overview
11.1.3 Merck Live Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Merck Live Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Corporation Information
11.2.2 GlaxoSmithKline Overview
11.2.3 GlaxoSmithKline Live Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 GlaxoSmithKline Live Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GlaxoSmithKline Recent Developments
11.3 Pfizer
11.3.1 Pfizer Corporation Information
11.3.2 Pfizer Overview
11.3.3 Pfizer Live Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Pfizer Live Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Pfizer Recent Developments
11.4 Novartis
11.4.1 Novartis Corporation Information
11.4.2 Novartis Overview
11.4.3 Novartis Live Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Novartis Live Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Novartis Recent Developments
11.5 Astellas Pharma
11.5.1 Astellas Pharma Corporation Information
11.5.2 Astellas Pharma Overview
11.5.3 Astellas Pharma Live Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Astellas Pharma Live Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Astellas Pharma Recent Developments
11.6 Emergent BioSolutions
11.6.1 Emergent BioSolutions Corporation Information
11.6.2 Emergent BioSolutions Overview
11.6.3 Emergent BioSolutions Live Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Emergent BioSolutions Live Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Emergent BioSolutions Recent Developments
11.7 AstraZeneca
11.7.1 AstraZeneca Corporation Information
11.7.2 AstraZeneca Overview
11.7.3 AstraZeneca Live Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 AstraZeneca Live Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 AstraZeneca Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Live Vaccines Industry Chain Analysis
12.2 Live Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Live Vaccines Production Mode & Process
12.4 Live Vaccines Sales and Marketing
12.4.1 Live Vaccines Sales Channels
12.4.2 Live Vaccines Distributors
12.5 Live Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Live Vaccines Industry Trends
13.2 Live Vaccines Market Drivers
13.3 Live Vaccines Market Challenges
13.4 Live Vaccines Market Restraints
14 Key Findings in The Global Live Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
